Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.

psilocybin (COMP360) - Compass Pathways

http://www.ncbi.nlm.nih.gov/pubmed/40883964

Agata Tofil-Kaluza; Guy M Goodwin; Hollie Simmons; James J Rucker; Manish Agrawal; Nadav Liam Modlin; Niall M McGowan; Rachel Yehuda; Shriya Das

Aug 30, 2025